Hoth Historical Balance Sheet

HOTH Stock

USD 0.85 0.01 1.16%

Trend analysis of Hoth Therapeutics balance sheet accounts such as Total Current Liabilities of 641.9 K or Total Stockholder Equity of 5.1 M provides information on Hoth Therapeutics' total assets, liabilities, and equity, which is the actual value of Hoth Therapeutics to its prevalent stockholders. By breaking down trends over time using Hoth Therapeutics balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Hoth Therapeutics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Hoth Therapeutics is a good buy for the upcoming year.

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hoth Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For more detail on how to invest in Hoth Stock please use our How to Invest in Hoth Therapeutics guide.

About Hoth Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Hoth Therapeutics at a specified time, usually calculated after every quarter, six months, or one year. Hoth Therapeutics Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Hoth Therapeutics and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Hoth currently owns. An asset can also be divided into two categories, current and non-current.

Hoth Therapeutics Balance Sheet Chart

As of now, Hoth Therapeutics' Total Liabilities is increasing as compared to previous years. The Hoth Therapeutics' current Property Plant And Equipment Gross is estimated to increase to about 57.9 K, while Total Assets are projected to decrease to under 5.8 M.

Total Assets Other Current Liab Total Stockholder Equity Net Debt Cash And Short Term Investments Other Current Assets

Add Fundamental

Total Assets

Total assets refers to the total amount of Hoth Therapeutics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Hoth Therapeutics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Net Debt

The total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds.

Cash And Short Term Investments

Short Term Investments is an account in the current assets section of Hoth Therapeutics balance sheet. This account contains Hoth Therapeutics investments that will expire within one year. These investments include stocks and bonds that can be liquidated by Hoth Therapeutics fairly quickly. The sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash.

Other Current Assets

Assets expected to be converted into cash, sold, or consumed either in one year or in the operating cycle, which are not included under standard current asset categories.

Most accounts from Hoth Therapeutics' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Hoth Therapeutics current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hoth Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For more detail on how to invest in Hoth Stock please use our How to Invest in Hoth Therapeutics guide.As of now, Hoth Therapeutics' Total Liabilities is increasing as compared to previous years. The Hoth Therapeutics' current Property Plant And Equipment Gross is estimated to increase to about 57.9 K, while Total Assets are projected to decrease to under 5.8 M.

	2021	2022	2023	2024 (projected)
Other Current Liabilities	506.8K	692.7K	585.4K	347.6K
Total Assets	11.0M	6.8M	9.5M	5.8M

Other Current Liab Total Assets

Hoth Therapeutics balance sheet Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Capital Surpluse	Other Stockholder Equity	Total Liab	Net Invested Capital	Property Plant And Equipment Gross	Total Current Assets	Net Working Capital	Common Stock	Property Plant Equipment	Retained Earnings Total Equity
Total Assets		0.88	0.8	1.0	0.92	0.45	-0.93	-0.88	0.44	0.97	0.64	0.0	1.0	0.92	-0.64	0.32	0.9	0.94	0.82	1.0	0.45	1.0	1.0	0.54	-0.81	-0.9
Other Current Liab	0.88		0.94	0.84	0.9	0.43	-0.87	-0.91	0.59	0.9	0.35	-0.08	0.88	0.84	-0.69	0.28	0.84	0.95	0.93	0.84	0.43	0.88	0.85	0.2	-0.79	-0.83
Total Current Liabilities	0.8	0.94		0.74	0.83	0.26	-0.78	-0.85	0.81	0.8	0.36	0.16	0.8	0.81	-0.76	0.49	0.81	0.87	0.99	0.74	0.26	0.8	0.75	0.21	-0.82	-0.84
Total Stockholder Equity	1.0	0.84	0.74		0.9	0.47	-0.92	-0.86	0.37	0.97	0.65	-0.02	1.0	0.9	-0.6	0.28	0.88	0.93	0.76	1.0	0.47	0.99	1.0	0.56	-0.78	-0.87
Net Tangible Assets	0.92	0.9	0.83	0.9		0.67	-0.99	-0.99	0.39	0.92	0.42	-0.06	0.92	0.83	-0.61	0.16	0.94	0.94	0.83	0.9	0.67	0.92	0.91	0.24	-0.75	-0.9
Property Plant And Equipment Net	0.45	0.43	0.26	0.47	0.67		-0.69	-0.69	-0.29	0.52	-0.05	-0.2	0.45	0.36	-0.22	-0.37	0.57	0.53	0.22	0.47	1.0	0.46	0.47	-0.22	-0.31	-0.41
Net Debt	-0.93	-0.87	-0.78	-0.92	-0.99	-0.69		0.96	-0.32	-0.95	-0.4	0.12	-0.94	-0.8	0.55	-0.09	-0.89	-0.92	-0.78	-0.92	-0.69	-0.94	-0.93	-0.29	0.7	0.84
Retained Earnings	-0.88	-0.91	-0.85	-0.86	-0.99	-0.69	0.96		-0.41	-0.9	-0.37	-0.01	-0.88	-0.85	0.66	-0.19	-0.94	-0.95	-0.84	-0.86	-0.69	-0.89	-0.87	-0.15	0.8	0.9
Accounts Payable	0.44	0.59	0.81	0.37	0.39	-0.29	-0.32	-0.41		0.41	0.31	0.48	0.44	0.56	-0.61	0.76	0.44	0.5	0.8	0.37	-0.29	0.44	0.38	0.24	-0.63	-0.55
Cash	0.97	0.9	0.8	0.97	0.92	0.52	-0.95	-0.9	0.41		0.45	-0.09	0.98	0.86	-0.53	0.18	0.84	0.96	0.79	0.97	0.52	0.98	0.97	0.37	-0.73	-0.82
Non Current Assets Total	0.64	0.35	0.36	0.65	0.42	-0.05	-0.4	-0.37	0.31	0.45		0.34	0.61	0.7	-0.65	0.67	0.64	0.46	0.47	0.65	-0.05	0.61	0.63	0.87	-0.7	-0.71
Non Currrent Assets Other	0.0	-0.08	0.16	-0.02	-0.06	-0.2	0.12	-0.01	0.48	-0.09	0.34		-0.02	0.27	-0.44	0.8	0.18	0.04	0.14	-0.02	-0.2	-0.01	-0.03	0.2	-0.45	-0.23
Cash And Short Term Investments	1.0	0.88	0.8	1.0	0.92	0.45	-0.94	-0.88	0.44	0.98	0.61	-0.02		0.91	-0.61	0.3	0.89	0.95	0.81	1.0	0.45	1.0	1.0	0.51	-0.8	-0.89
Common Stock Total Equity	0.92	0.84	0.81	0.9	0.83	0.36	-0.8	-0.85	0.56	0.86	0.7	0.27	0.91		-0.77	0.55	0.93	0.93	0.84	0.9	0.36	0.91	0.9	0.45	-0.94	-0.95
Common Stock Shares Outstanding	-0.64	-0.69	-0.76	-0.6	-0.61	-0.22	0.55	0.66	-0.61	-0.53	-0.65	-0.44	-0.61	-0.77		-0.73	-0.79	-0.66	-0.77	-0.6	-0.22	-0.63	-0.59	-0.44	0.93	0.8
Non Current Liabilities Total	0.32	0.28	0.49	0.28	0.16	-0.37	-0.09	-0.19	0.76	0.18	0.67	0.8	0.3	0.55	-0.73		0.41	0.3	0.53	0.28	-0.37	0.31	0.27	0.54	-0.71	-0.53
Capital Surpluse	0.9	0.84	0.81	0.88	0.94	0.57	-0.89	-0.94	0.44	0.84	0.64	0.18	0.89	0.93	-0.79	0.41		0.91	0.84	0.88	0.57	0.89	0.88	0.36	-0.9	-0.98
Other Stockholder Equity	0.94	0.95	0.87	0.93	0.94	0.53	-0.92	-0.95	0.5	0.96	0.46	0.04	0.95	0.93	-0.66	0.3	0.91		0.87	0.93	0.53	0.95	0.93	0.26	-0.84	-0.9
Total Liab	0.82	0.93	0.99	0.76	0.83	0.22	-0.78	-0.84	0.8	0.79	0.47	0.14	0.81	0.84	-0.77	0.53	0.84	0.87		0.76	0.22	0.82	0.77	0.29	-0.84	-0.88
Net Invested Capital	1.0	0.84	0.74	1.0	0.9	0.47	-0.92	-0.86	0.37	0.97	0.65	-0.02	1.0	0.9	-0.6	0.28	0.88	0.93	0.76		0.47	0.99	1.0	0.56	-0.78	-0.87
Property Plant And Equipment Gross	0.45	0.43	0.26	0.47	0.67	1.0	-0.69	-0.69	-0.29	0.52	-0.05	-0.2	0.45	0.36	-0.22	-0.37	0.57	0.53	0.22	0.47		0.46	0.47	-0.22	-0.31	-0.41
Total Current Assets	1.0	0.88	0.8	0.99	0.92	0.46	-0.94	-0.89	0.44	0.98	0.61	-0.01	1.0	0.91	-0.63	0.31	0.89	0.95	0.82	0.99	0.46		1.0	0.52	-0.81	-0.89
Net Working Capital	1.0	0.85	0.75	1.0	0.91	0.47	-0.93	-0.87	0.38	0.97	0.63	-0.03	1.0	0.9	-0.59	0.27	0.88	0.93	0.77	1.0	0.47	1.0		0.54	-0.78	-0.87
Common Stock	0.54	0.2	0.21	0.56	0.24	-0.22	-0.29	-0.15	0.24	0.37	0.87	0.2	0.51	0.45	-0.44	0.54	0.36	0.26	0.29	0.56	-0.22	0.52	0.54		-0.46	-0.45
Property Plant Equipment	-0.81	-0.79	-0.82	-0.78	-0.75	-0.31	0.7	0.8	-0.63	-0.73	-0.7	-0.45	-0.8	-0.94	0.93	-0.71	-0.9	-0.84	-0.84	-0.78	-0.31	-0.81	-0.78	-0.46		0.92
Retained Earnings Total Equity	-0.9	-0.83	-0.84	-0.87	-0.9	-0.41	0.84	0.9	-0.55	-0.82	-0.71	-0.23	-0.89	-0.95	0.8	-0.53	-0.98	-0.9	-0.88	-0.87	-0.41	-0.89	-0.87	-0.45	0.92

Click cells to compare fundamentals

Hoth Therapeutics Account Relationship Matchups

Hoth Therapeutics balance sheet Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	2.8M	5.2M	11.0M	6.8M	9.5M	5.8M
Other Current Liab	36.2K	182.7K	506.8K	692.7K	585.4K	347.6K
Total Current Liabilities	440.1K	312.1K	867.8K	1.4M	678.7K	641.9K
Total Stockholder Equity	2.4M	4.6M	9.9M	5.1M	8.8M	5.1M
Net Tangible Assets	154.7K	2.4M	4.6M	9.9M	11.4M	11.9M
Net Debt	(1.7M)	(2.6M)	(8.5M)	(6.4M)	(9.2M)	(8.8M)
Retained Earnings	(12.2M)	(19.4M)	(33.7M)	(45.1M)	(52.9M)	(50.3M)
Accounts Payable	403.9K	129.5K	361.0K	695.0K	35.6K	33.8K
Cash	1.7M	2.6M	8.5M	6.4M	9.3M	4.7M
Non Current Assets Total	201.0K	460K	410K	33K	92.6K	87.9K
Non Currrent Assets Other	200K	50K	0.0	33K	(1.0)	(0.95)
Cash And Short Term Investments	2.5M	4.7M	10.4M	6.6M	9.3M	5.5M
Common Stock Shares Outstanding	366.6K	494.5K	893.2K	1.2M	3.4M	1.8M
Liabilities And Stockholders Equity	2.8M	5.2M	11.0M	6.8M	9.5M	5.8M
Non Current Liabilities Total	403.9K	285K	235K	250K	26.3K	25.0K
Other Stockholder Equity	14.6M	24.1M	43.6M	50.2M	61.7M	31.8M
Total Liab	440.1K	597.1K	1.1M	1.6M	705.0K	767.0K
Net Invested Capital	2.4M	4.6M	9.9M	5.1M	8.8M	5.1M
Total Current Assets	2.6M	4.8M	10.6M	6.7M	9.4M	5.6M
Accumulated Other Comprehensive Income	0.0	(15.4K)	17.6K	22.0K	27.3K	28.6K
Net Working Capital	2.2M	4.5M	9.7M	5.3M	8.7M	5.0M
Common Stock	1.0K	1.3K	2.4K	130.0	435.0	413.25
Other Current Assets	140.6K	89.8K	94.0K	88.5K	135.4K	102.3K
Capital Stock	1.0K	1.3K	2.4K	130.0	435.0	818.0

Currently Active Assets on Macroaxis

C	Citigroup
GM	General Motors
F	Ford Motor
GM	General Motors
V	Visa Class A

When determining whether Hoth Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Hoth Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Hoth Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Hoth Therapeutics Stock:

How To Invest In Hoth

Details

Is Hoth Stock a good investment?

Details

What is Hoth Therapeutics' Net Worth?

Details

Largest Pharmaceuticals Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

For more detail on how to invest in Hoth Stock please use our How to Invest in Hoth Therapeutics guide.

You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Hoth Therapeutics. If investors know Hoth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Hoth Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(1.27)

Return On Assets

(0.46)

Return On Equity

(0.83)

The market value of Hoth Therapeutics is measured differently than its book value, which is the value of Hoth that is recorded on the company's balance sheet. Investors also form their own opinion of Hoth Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Hoth Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Hoth Therapeutics' market value can be influenced by many factors that don't directly affect Hoth Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Hoth Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Hoth Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Hoth Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Hoth Historical Balance Sheet

About Hoth Balance Sheet Analysis

Hoth Therapeutics Balance Sheet Chart

Total Assets

Total Stockholder Equity

Net Debt

Cash And Short Term Investments

Other Current Assets

Hoth Therapeutics balance sheet Correlations

Hoth Therapeutics Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Hoth Therapeutics balance sheet Accounts

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Total Assets
Net Invested Capital	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Net Working Capital	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Total Stockholder Equity

Retained Earnings	- 0.99	Net Tangible Assets
Net Debt	- 0.99	Net Tangible Assets
Retained Earnings Total Equity	- 0.98	Capital Surpluse
Retained Earnings Total Equity	- 0.95	Common Stock Total Equity
Other Stockholder Equity	- 0.95	Retained Earnings
Cash	- 0.95	Net Debt